- FDA Says First Round of Tests Show No Live Virus in Pasteurized Milk
- King Charles Returns to Duties After Cancer Treatment
- Biden Administration Delays Menthol Cigarette Ban
- Blood Test Might Predict Knee Osteoarthritis Years Early
- Dogs Can Get Lyme Disease, Too
- Spinal Cord Injury Damages Metabolism, and Scientists Now Know Why
- Syphilis Is Increasingly Displaying Atypical, Severe Symptoms
- Climate Change Could Be Good News for Viruses Like COVID
- Vaccines Have Saved 154 Million Lives, Mostly Babies, Over Past 50 Years
- Scientists Discover Cause of Rare Movement Disorder
Generic Aciphex Approved to Treat Chronic Heartburn
FRIDAY, Nov. 8The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
Gastroesophageal reflux disease (GERD), also known as chronic heartburn, is a very common disorder characterized by backward flow of stomach acid to the esophagus. This process could damage tissue in the esophagus, the tube that connects the throat and stomach.
License to produce generic rabeprazole was granted to Dr. Reddy’s Laboratories, Kremers Urban Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals and Torrent Pharmaceuticals, the FDA said.
The drug is among a class called proton-pump inhibitors, which are designed to reduce the amount of stomach acid produced. Generic drugs, the FDA stressed, are equivalent to the brand-name versions in strength and quality.
More information
To learn more about GERD, visit Medline Plus.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.